financetom
Business
financetom
/
Business
/
Sutro Biopharma Opens Enrollment for Luveltamab Tazevibulin Trial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sutro Biopharma Opens Enrollment for Luveltamab Tazevibulin Trial
Nov 1, 2024 6:19 AM

08:46 AM EDT, 11/01/2024 (MT Newswires) -- Sutro Biopharma ( STRO ) said Friday it has opened enrollment for its registration-directed study of the drug luveltamab tazevibulin in children with a certain type of acute myeloid leukemia.

The trial is global and the majority of the sites are planned to be open by the end of the year, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ginkgo Bioworks Stock Plummets Following Q3 Estimates Miss, Reaffirms FY2025 Outlook Below Consensus
Ginkgo Bioworks Stock Plummets Following Q3 Estimates Miss, Reaffirms FY2025 Outlook Below Consensus
Nov 7, 2025
Ginkgo Bioworks Holdings Inc ( DNA ) shares are trading lower on Friday. The company released its third-quarter financial results. What To Know: Ginkgo Bioworks ( DNA ) reported a loss of $1.45 per share versus estimates for a loss of $1.24 per share and a loss of $1.08 per share in the same period last year, representing a 34.26%...
Why Is Clearmind Stock Down Today?
Why Is Clearmind Stock Down Today?
Nov 7, 2025
Shares of Clearmind Medicine Inc. ( CMND ) are falling Friday after the clinical-stage biotech company shared a key update about its stock listing. What To Know: Clearmind said it received a Nasdaq delisting notification last week. Nasdaq requires companies to maintain a minimum of $2.5 million in stockholders’ equity. However, on a Form 6-K that Clearmind filed in September, it reported...
--Chemed Keeps Quarterly Dividend at $0.60 per Share, Payable Dec. 5 to Holders of Record on Nov. 17
--Chemed Keeps Quarterly Dividend at $0.60 per Share, Payable Dec. 5 to Holders of Record on Nov. 17
Nov 7, 2025
02:40 PM EST, 11/07/2025 (MT Newswires) -- Price: 433.33, Change: +2.74, Percent Change: +0.64 ...
Disney Executives Reportedly Inform Staff YouTube TV Deal Still Stalled
Disney Executives Reportedly Inform Staff YouTube TV Deal Still Stalled
Nov 7, 2025
02:42 PM EST, 11/07/2025 (MT Newswires) -- Walt Disney's ( DIS ) Disney Entertainment Co-Chairs Dana Walden and Alan Bergman, along with ESPN ( DIS ) Chairman Jimmy Pitaro, said in a staff memo that the Alphabet (GOOG, GOOGL) YouTube ( GOOG ) blackout would continue another sports-heavy weekend, multiple media outlets reported Friday, citing the memo. The news follows...
Copyright 2023-2026 - www.financetom.com All Rights Reserved